About us

 

Emeriti Pharma

Experience and creativity

Emeriti Pharma, a privately owned Swedish company, was founded in 2014 by former AstraZeneca scientists representing a wide knowledge of pharmaceutical research and development, often with many years in leading positions, and with experience of taking innovative drugs to the market.

 

Björn Wallmark - Chairman of the Board, PhD in biochemistry, worked with AstraZeneca for 27 years, and Schering AG for 5 years. Co-founder of Emeriti Pharma.

David Gustafsson - CEO, MD and PhD in pharmacology, worked with AstraZeneca for 28 years. Co-founder of Emeriti Pharma.

Tomas Fex - Member of the Board, PhD in organic chemistry, 30 years of experience from pharmaceutical companies in Sweden, 10 years at AstraZeneca. Co-founder of Emeriti Pharma.

Bengt Ohlsson - PhD in organic chemistry, worked with AstraZeneca for 25 years. Co-founder of Emeriti Pharma.

Lars Gustafsson - Member of the Board, previous managing director and chairman of the Nordic branch of Euler Hermes, a credit insurance company.

 

Registered drugs and brands that we have had a major influence on: Losec®/Prilosec®, Nexium®, Plendil®, Exanta®, Brilinta®

Copyright © All Rights Reserved